Philip Newsholme

11PUBLICATIONS
20CO-AUTHORS
Food properties (incl. characteristics and health benefits)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursGlycobiologyCell development, proliferation and death
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 23, 2022
Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer's Disease.

Amy Woodfield, Tatiana Gonzales, Erik Helmerhorst

|Dec 23, 2022
Butyrate Lowers Cellular Cholesterol through HDAC Inhibition and Impaired SREBP-2 Signalling.

Stephanie Bridgeman, Hon Chiu Woo, Philip Newsholme

|Jan 21, 2022
Metabolic Adaptions/Reprogramming in Islet Beta-Cells in Response to Physiological Stimulators-What Are the Consequences.

Philip Newsholme, Jordan Rowlands, Roselyn Rose'Meyer

|Dec 24, 2021
The HDAC Inhibitor Butyrate Impairs β Cell Function and Activates the Disallowed Gene Hexokinase I.

Stephanie Bridgeman, Gaewyn Ellison, Philip Newsholme

|Aug 27, 2021
The Immunometabolic Roles of Various Fatty Acids in Macrophages and Lymphocytes.

Jose Cesar Rosa Neto, Philip C Calder, Rui Curi

Pageof 2